Title:
微小胞膜タンパク質及びその応用
Document Type and Number:
Japanese Patent JP5808288
Kind Code:
B2
Abstract:
Microvesicles play essential roles in disease progression. The present invention provides a novel microvesicle membrane protein and application thereof. Disclosed is method comprises phosphorylated CSE1L (cellular apoptosis susceptibility protein)- or CSE1L-binding agents for microvesicle isolation, analysis, or binding for disease diagnosis or treatment.
Inventors:
JIANG,Ming-Chung
Application Number:
JP2012109698A
Publication Date:
November 10, 2015
Filing Date:
May 11, 2012
Export Citation:
Assignee:
JIANG,Ming-Chung
International Classes:
C12Q1/04; C07K16/28; G01N33/574
Domestic Patent References:
| JP2007282513A |
Foreign References:
| US20100120074 |
Other References:
Tsai et al,The American Journal of Patbology,2010年 4月,Vol. 176, No. 4,p. 1619-1628
Scherf et al,Biochemical and Biophysical Research Communications,1998年,Vol. 250,p. 623-628
Tung et al,Cancer Epidemiology, Biomarkers & Prevention,2009年 5月,Vol. 18, No. 5,p. 1570-1577
Liao et al,Molecular Medicine,2012年,Vol. 18,p. 1269-1280
Tai et al,Experimental Cell Research,2010年,Vol. 316,p. 2969-2981
Scherf et al,Biochemical and Biophysical Research Communications,1998年,Vol. 250,p. 623-628
Tung et al,Cancer Epidemiology, Biomarkers & Prevention,2009年 5月,Vol. 18, No. 5,p. 1570-1577
Liao et al,Molecular Medicine,2012年,Vol. 18,p. 1269-1280
Tai et al,Experimental Cell Research,2010年,Vol. 316,p. 2969-2981
Attorney, Agent or Firm:
sk patent corporation
Akihiko Okuno
Hiroyuki Ito
Akihiko Okuno
Hiroyuki Ito